OTCMKTS:GTBIF

Green Thumb Industries Competitors

$28.10
+1.10 (+4.07 %)
(As of 04/9/2021 08:27 PM ET)
Add
Compare
Today's Range
$26.53
Now: $28.10
$28.22
50-Day Range
$25.35
MA: $32.38
$36.77
52-Week Range
$5.37
Now: $28.10
$39.11
Volume309,400 shs
Average Volume857,272 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Green Thumb Industries (OTCMKTS:GTBIF) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying GTBIF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Green Thumb Industries, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

Abacus Health Products (OTCMKTS:ABAHF) and Green Thumb Industries (OTCMKTS:GTBIF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Profitability

This table compares Abacus Health Products and Green Thumb Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abacus Health ProductsN/AN/AN/A
Green Thumb IndustriesN/AN/AN/A

Valuation & Earnings

This table compares Abacus Health Products and Green Thumb Industries' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abacus Health ProductsN/AN/AN/AN/AN/A
Green Thumb IndustriesN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings for Abacus Health Products and Green Thumb Industries, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abacus Health Products0000N/A
Green Thumb Industries001103.00

Green Thumb Industries has a consensus target price of $48.5750, indicating a potential upside of 72.86%. Given Green Thumb Industries' higher probable upside, analysts plainly believe Green Thumb Industries is more favorable than Abacus Health Products.

Summary

Green Thumb Industries beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Green Thumb Industries (OTCMKTS:GTBIF) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Green Thumb Industries and Acreage, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Green Thumb Industries001103.00
Acreage01202.67

Green Thumb Industries currently has a consensus target price of $48.5750, suggesting a potential upside of 72.86%. Acreage has a consensus target price of $8.4333, suggesting a potential upside of 204.45%. Given Acreage's higher probable upside, analysts clearly believe Acreage is more favorable than Green Thumb Industries.

Profitability

This table compares Green Thumb Industries and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Green Thumb IndustriesN/AN/AN/A
AcreageN/AN/AN/A

Earnings and Valuation

This table compares Green Thumb Industries and Acreage's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Green Thumb IndustriesN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Summary

Green Thumb Industries beats Acreage on 2 of the 3 factors compared between the two stocks.

Green Thumb Industries (OTCMKTS:GTBIF) and Applied Biosciences (OTCMKTS:APPB) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Green Thumb Industries and Applied Biosciences, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Green Thumb Industries001103.00
Applied Biosciences0000N/A

Green Thumb Industries currently has a consensus target price of $48.5750, suggesting a potential upside of 72.86%. Given Green Thumb Industries' higher probable upside, research analysts clearly believe Green Thumb Industries is more favorable than Applied Biosciences.

Profitability

This table compares Green Thumb Industries and Applied Biosciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Green Thumb IndustriesN/AN/AN/A
Applied BiosciencesN/AN/AN/A

Earnings and Valuation

This table compares Green Thumb Industries and Applied Biosciences' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Green Thumb IndustriesN/AN/AN/AN/AN/A
Applied BiosciencesN/AN/AN/AN/AN/A

Summary

Green Thumb Industries beats Applied Biosciences on 2 of the 2 factors compared between the two stocks.

Ayr Strategies (OTCMKTS:AYRSF) and Green Thumb Industries (OTCMKTS:GTBIF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Analyst Recommendations

This is a summary of current ratings and price targets for Ayr Strategies and Green Thumb Industries, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ayr Strategies01602.86
Green Thumb Industries001103.00

Ayr Strategies currently has a consensus price target of $34.8571, suggesting a potential upside of 63.96%. Green Thumb Industries has a consensus price target of $48.5750, suggesting a potential upside of 72.86%. Given Green Thumb Industries' stronger consensus rating and higher probable upside, analysts clearly believe Green Thumb Industries is more favorable than Ayr Strategies.

Profitability

This table compares Ayr Strategies and Green Thumb Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ayr StrategiesN/AN/AN/A
Green Thumb IndustriesN/AN/AN/A

Valuation & Earnings

This table compares Ayr Strategies and Green Thumb Industries' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ayr StrategiesN/AN/AN/AN/AN/A
Green Thumb IndustriesN/AN/AN/AN/AN/A

Summary

Green Thumb Industries beats Ayr Strategies on 3 of the 3 factors compared between the two stocks.

Can B (NASDAQ:CANB) and Green Thumb Industries (OTCMKTS:GTBIF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability.

Analyst Ratings

This is a summary of current ratings and recommmendations for Can B and Green Thumb Industries, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Can B0000N/A
Green Thumb Industries001103.00

Green Thumb Industries has a consensus price target of $48.5750, suggesting a potential upside of 72.86%. Given Green Thumb Industries' higher possible upside, analysts plainly believe Green Thumb Industries is more favorable than Can B.

Profitability

This table compares Can B and Green Thumb Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Can BN/AN/AN/A
Green Thumb IndustriesN/AN/AN/A

Earnings and Valuation

This table compares Can B and Green Thumb Industries' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Can BN/AN/AN/AN/AN/A
Green Thumb IndustriesN/AN/AN/AN/AN/A

Summary

Green Thumb Industries beats Can B on 2 of the 2 factors compared between the two stocks.

Cansortium (OTCMKTS:CNTMF) and Green Thumb Industries (OTCMKTS:GTBIF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability.

Earnings and Valuation

This table compares Cansortium and Green Thumb Industries' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CansortiumN/AN/AN/AN/AN/A
Green Thumb IndustriesN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and recommmendations for Cansortium and Green Thumb Industries, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cansortium00103.00
Green Thumb Industries001103.00

Cansortium presently has a consensus price target of $1.20, suggesting a potential upside of 41.18%. Green Thumb Industries has a consensus price target of $48.5750, suggesting a potential upside of 72.86%. Given Green Thumb Industries' higher possible upside, analysts plainly believe Green Thumb Industries is more favorable than Cansortium.

Profitability

This table compares Cansortium and Green Thumb Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CansortiumN/AN/AN/A
Green Thumb IndustriesN/AN/AN/A

Summary

Green Thumb Industries beats Cansortium on 2 of the 2 factors compared between the two stocks.

pixel
Ad Home Bistro
The Next Household Brand in At Home Dining
Newcomer HBIS is taking the home delivery, eat-at-home market by storm with all new menus, celebrity chef status and a convenience factor that will change the way we prepare home cooked meals forever.

Green Thumb Industries Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84+5.4%$0.00N/A0.00Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77+0.9%$0.00N/A0.00
APPB
Applied Biosciences
0.5$0.25+92.0%$0.00N/A0.00High Trading Volume
Gap Down
AYRSF
Ayr Strategies
1.4$21.26+1.0%$0.00N/A0.00High Trading Volume
Gap Down
Can B logo
CANB
Can B
0.4$0.55+1.8%$0.00N/A0.00High Trading Volume
Cansortium logo
CNTMF
Cansortium
1.1$0.85+1.8%$0.00N/A0.00
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.51+0.8%$0.00N/A0.00
Choom logo
CHOOF
Choom
0.5$0.10+7.1%$0.00N/A0.00
CPHRF
Cipher Pharmaceuticals
1.2$1.08+0.5%$0.00N/A0.00Gap Up
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.22+8.6%$0.00N/A0.00
Cosmos logo
COSM
Cosmos
0.5$5.80+0.9%$0.00N/A0.00
Cresco Labs logo
CRLBF
Cresco Labs
1.5$12.73+1.1%$0.00N/A0.00
Curaleaf logo
CURLF
Curaleaf
1.6$14.70+0.1%$0.00N/A0.00
HMDEF
DionyMed Brands
0.5$2.25+1.5%$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00+29.4%$0.00N/A0.00Gap Up
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15+3.4%$0.00N/A0.00Gap Up
EVIO
EVIO
0.6$0.00+3.7%$0.00N/A0.00Gap Down
Flower One logo
FLOOF
Flower One
0.4$0.28+3.2%$0.00N/A0.00
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05+5.0%$0.00N/A0.00
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01+3.6%$0.00N/A0.00Gap Up
GTEC logo
GGTTF
GTEC
0.6$0.62+3.4%$0.00N/A0.00
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$3.06+2.0%$0.00N/A0.00
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01+3.3%$0.00N/A0.00
Hexo logo
HYYDF
Hexo
0.6$5.30+1.8%$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$59.68+4.6%$0.00N/A0.00Gap Up
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.24+7.5%$0.00N/A0.00Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.36+0.6%$0.00N/A0.00
KNHBF
ICC International Cannabis
0.6$0.43+0.0%$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04+4.6%$0.00N/A0.00Gap Up
Isodiol International logo
ISOLF
Isodiol International
0.4$0.06+13.1%$0.00N/A0.00Gap Up
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.45+0.9%$0.00N/A0.00
KHTRF
Knight Therapeutics
1.2$4.22+0.3%$0.00N/A0.00High Trading Volume
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01+3.6%$0.00N/A0.00
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.06+3.1%$0.00N/A0.00Gap Down
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.42+8.2%$0.00N/A0.00
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.37+3.6%$0.00N/A0.00
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$35.31+1.4%$0.00N/A0.00High Trading Volume
MJardin Group logo
MJARF
MJardin Group
1.1$0.07+2.6%$0.00N/A0.00Gap Up
MYHI
Mountain High Acquisitions
0.5$0.02+0.0%$0.00N/A0.00Gap Down
PHCEF
Pharmacielo
0.7$2.42+0.8%$0.00N/A0.00
Plus Products logo
PLPRF
Plus Products
1.1$0.57+0.9%$0.00N/A0.00Gap Down
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00+4.0%$0.00N/A0.00
PCYN
Procyon
0.4$0.70+7.1%$0.00N/A0.00Gap Up
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01+5.5%$0.00N/A0.00
SANP
Santo Mining
0.5$0.01+7.2%$0.00N/A0.00Gap Down
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$13.39+1.6%$0.00N/A0.00
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40+7.8%$0.00N/A0.00Gap Up
TerrAscend logo
TRSSF
TerrAscend
1.7$10.11+2.4%$0.00N/A0.00Gap Down
The Flowr logo
FLWPF
The Flowr
1.5$0.26+2.0%$0.00N/A0.00
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.0$0.32+0.8%$0.00N/A0.00Analyst Downgrade
Gap Up
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.